Oral Abstracts
OA 17.06 Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%

https://doi.org/10.1016/j.jtho.2017.09.431Get rights and content
Under an Elsevier user license
open archive

Cited by (0)